U50
Drug resistant tuberculosis
- U50.00Primary multidrug resistant tuberculosis (MDR TB)
- U50.01Secondary multidrug resistant tuberculosis (MDR TB)
- U50.10Drug resistant tuberculosis, primary resistance to isoniazid (INH) only
- U50.11Drug resistant tuberculosis, secondary resistance to isoniazid (INH) only
- U50.20Drug resistant tuberculosis, primary resistance to rifampicin only
- U50.21Drug resistant tuberculosis, secondary resistance to rifampicin only
- U50.30Drug resistant tuberculosis, primary resistance to isoniazid (INH) and rifampicin and any other anti-tuberculosis drug
- U50.31Drug resistant tuberculosis, secondary resistance to isoniazid (INH) and rifampicin and any other anti-tuberculosis drug
- U50.40Drug resistant tuberculosis, primary resistance to isoniazid (INH) and rifampicin and any drug not classified as an anti-tuberculosis drug, including antibiotics, anti-leprotics, etc
- U50.41Drug resistant tuberculosis, secondary resistance to isoniazid (INH) and rifampicin and any drug not classified as an anti-tuberculosis drug, including antibiotics, anti-leprotics, etc
- U50.50Extensively drug resistant tuberculosis, primary resistance to INH and rifampicin, and any fluoroquinolone plus capreomycin and/or kanamicin and/or amikacin
- U50.51Extensively drug resistant tuberculosis, secondary resistance to isoniazid and rifampicin, and any fluoroquinolone plus one of: capreomycin and/or kanamicin and/or amikacin
- U50.60Extensively drug resistant tuberculosis, primary resistance to INH and rifampicin, and any fluoroquinolone plus other specified second-line injectable anti-TB drug
- U50.61Extensively drug resistant tuberculosis, secondary resistance to INH and rifampicin, and any fluoroquinolone plus other specified second-line injectable anti-TB drug
- U50.90Drug resistant tuberculosis, primary resistance to drug, unspecified
- U50.91Drug resistant tuberculosis, secondary resistance to drug, unspecified